Terri Wilder, M.S.W.
Terri L. Wilder, M.S.W., has been part of the HIV community since 1989, and has been a reporter and writer for TheBody/TheBodyPro since 2007. She served on the New York Governor's Task Force to End AIDS, was recognized by POZ magazine for her work in HIV, and is highlighted in the book Fag Hags, Divas and Moms: The Legacy of Straight Women in the AIDS Community by Victoria Noe. She loves this community and will keep fighting until the epidemic is over.
Latest by Terri Wilder, M.S.W.
Caring for Transgender Individuals: Interview With a Transgender Medicine Specialist
"Being transgender is not necessarily an HIV risk factor," Joshua D. Safer, M.D., says.
New Website Helps People Trying to Navigate Their PrEP Options
A team led by Shannon Weber, M.S.W., has developed PleasePrEPMe, an online PrEP provider search and chat service.
Are Urgent Care Centers Prescribing PrEP? Researchers Explore the Answer
A new CDC study suggests that many urgent care centers in the U.S. still need to be made aware of pre-exposure prophylaxis and how to provide it.
Plan to End HIV Epidemic in U.S. Must Contend With Uneven State Health Care Systems
Best practices need to be replicated, but our health care structure will make doing so more challenging, says Ace Robinson of the Fast-Track Cities initiative.
Primary Care Providers Aware of PrEP in NYC Suburbs, but Report Barriers to Prescribing
Anthony J. Santella, Dr.P.H., explains why prevention efforts are lagging within the largest suburban HIV epidemic in the U.S.
Helping Providers Increase Capacity to Care for Patients on PrEP
A poster presentation at the AIDS 2018 conference examined some of the challenges and barriers providers experience in screening and prescribing PrEP to their patients.
Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant
New information was presented at the 2018 International AIDS Conference in Amsterdam about babies born with neural tube defects to women with HIV who started a regimen with dolutegravir (Tivicay, DTG) and then later got pregnant.
HIV Activist David Barr on Going Beyond 90-90-90
Barr, a longtime AIDS activist and co-founder of Treatment Action Group (TAG), was the coordinator for the Joep Lange Institute's AIDS 2018 preconference workshop, Meeting the 90-90-90 Targets: Faster and Better.
Anthony Fauci Discusses Research Approaches to Sustaining HIV Remission Without Antiretroviral Therapy
Fauci spoke to TheBodyPRO at this year's International AIDS Conference on approaches to HIV remission and durable control of HIV without antiretroviral therapy.
Anthony Fauci Traces the HIV Research Path to U=U
At this year's AIDS 2018 in Amsterdam, Fauci detailed the scientific research that lead us on the path to the discovery that undetectable equals untransmittable (U=U).